Cooperative Agreement 2506634
Award Date
6/15/25
Completion Date
5/31/27
Dollars Obligated
$1.3M
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Cooperative Agreement
Place of Performance
Baltimore, MD 21215, USA
Similar Awards
This Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to address the growing syphilis epidemic and prevent congenital syphilis infections. The $212,357 project, to be completed by July 2026, has three key objectives: Develop a point-of-care nucleic acid test (POC NAT) on a microfluidic rapid and autonomous analytical device (MicroRAAD) with a colorimetric readout for...
This National Science Foundation (NSF) Project Grant award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $298,646 to Anvil Diagnostics Inc. to develop a rapid diagnostic test for sepsis-causing pathogens in plasma samples. The project aims to create a sensitive, comprehensive panel that can identify a wide range of sepsis-causing microbes from small blood volumes, a critical capability for at-risk newborns. The proposed innovations leverage digital...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop an integrated multiplexed diagnostic assay for the rapid detection and semi-quantification of treponemal and nontreponemal antibodies associated with syphilis infection. The $698,349 award, spanning from February 2025 to January 2029, will support the creation of an electrochemical sensing platform...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Quarksen LLC provides funding to develop an affordable, point-of-care diagnostic device for detecting viral and non-viral sexually transmitted infections (STIs) such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, and trichomoniasis. The project aims to create a device with an array of sensors that can rapidly and accurately detect STI biomarkers from cervical...
This $233,250 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop rapid point-of-care assays for detecting antibiotic resistance in the bacteria that causes syphilis, Treponema pallidum. The key products to be delivered under this 2-year grant include: A multiplexed, point-of-care loop-mediated isothermal amplification (LAMP) assay to detect single nucleotide...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award supports the development of a novel device that can rapidly and automatically extract pathogen DNA from whole blood samples to enable faster diagnosis of sepsis. The $274,858 award to New England Hemolytics, Inc., with a project period from September 1, 2024 to February 28, 2025, will fund the testing and optimization of this technology across common sepsis-causing pathogens. The...
The National Science Foundation (NSF) awarded a $550,000 Project Grant under the NSF Technology, Innovation, and Partnerships (TIP) program to the University of California, Los Angeles (UCLA) to develop a rapid, multiplexed diagnostic tool for serological testing of tick-borne diseases (TBDs). This 2-year project seeks to improve blood-based detection of TBDs, including Lyme disease, Babesia, Anaplasma, and relapsing fever, through an innovative point-of-care (POC) serological assay. The goal is...
SBIR PHASE I: ACOUSTIC SENSOR BASED POINT OF CARE DIAGNOSTIC PLATFORM FOR RAPID IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TESTING -THE BROADER IMPACT/COMMERCIAL POTENTIAL OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I PROJECT LIES IN ADDRESSING THE GROWING GLOBAL BURDEN OF ANTIBIOTIC-RESISTANT URINARY TRACT INFECTIONS (UTIS), WHICH AFFECT AN ESTIMATED 150 MILLION PEOPLE ANNUALLY. CURRENT DIAGNOSTIC METHODS ARE SLOW, REQUIRING DAYS TO DELIVER RESULTS, WHICH DELAYS EFFECTIVE...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $304,966 to Kompass Diagnostics Inc., a small business located in Chicago, Illinois, will support the development of a portable, rapid point-of-care diagnostic device for detecting multiple blood-based biomarkers. The key objectives of this award are to: (1) develop an integrated cartridge/analyzer system that automates serum separation and buffer dilution to enable...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $260,760 Project Grant to the University of Victoria (Advancement Services) to develop a direct diagnostic test for infectious and congenital syphilis. The proposed test aims to exhibit high sensitivity and specificity, differentiate active versus past infections, distinguish syphilis from yaws, enable accurate disease staging, and be adaptable to...